🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the MycarinGstudy is to demonstrate the clinical efficacy an...
Status
Completed
Location
Mg0003 50081
Start Date
2019-06-03
Trial ID
NCT03971422
Treatments Being Tested
The purpose of this study is to demonstrate the clinical efficacy of rozano...
Status
Terminated
Location
Tp0003 50244
Start Date
2020-01-31
Trial ID
NCT04200456
Treatments Being Tested
The purpose of the study is to assess the long term safety and tolerability...
Status
Enrolling By Invitation
Location
Mg0008 40290
Start Date
2024-10-08
Trial ID
NCT06540144
Treatments Being Tested
The primary objective of the study is to check if an subcutaneous (sc) infu...
Status
Completed
Location
Tp0001 1101
Start Date
2016-03-02
Trial ID
NCT02718716
Treatments Being Tested
The purpose of the MycarinGstudy is to evaluate the long-term safety, toler...
Status
Completed
Location
Mg0004 50081
Start Date
2019-10-29
Trial ID
NCT04124965
Treatments Being Tested
The purpose of the study is to evaluate clinical efficacy of rozanolixizuma...
Status
Completed
Location
Cidp01 902
Start Date
2019-03-26
Trial ID
NCT03861481
Treatments Being Tested
This study is designed to evaluate the safety and tolerability of single as...
Status
Completed
Location
001
Start Date
2014-07
Trial ID
NCT02220153
The purpose of the study is to evaluate the clinical efficacy of UCB7665 as...
Status
Completed
Location
Mg0002 712
Start Date
2017-05-15
Trial ID
NCT03052751
The purpose of this study is to assess the safety, tolerability and efficac...
Status
Completed
Location
Mg0007 50092
Start Date
2021-02-03
Trial ID
NCT04650854
Treatments Being Tested
The purpose of the study is to evalute the efficacy, safety and tolerabilit...
Status
Active Not Recruiting
Location
Mog001 50297
Start Date
2022-02-02
Trial ID
NCT05063162
Treatments Being Tested